is hair loss condition that affects approximately 1 in every 1,000 people at some point in their lives. Korean company AesMed may have developed a new form of treatment for Alopecia which uses 'cytokines therapy' to activate hair cells.
The company developed 'the world's first hair loss treatment by using growth factors' in 2008, and today 'Systemic Growth Factors 57', known as SGF-57, is used in university hospitals, cosmetic surgery clinics and dermatology departments across Korea.
SGF-57 is said to be effective in the treatment of hair loss, due to the blend of cytokine and growth factors of SCF, KGF, VEGF, IFG-I, rh-SOD and bFGF, which, when blended together, can help to regulate shedding whilst boosting growth. A representative for AesMed stated: “Cytokine is proven by many medical journals to differentiate and proliferate hair cells and control hair growth cycle. In more than 600,000 cases for performing alopecia treatment, SGF-57 has been proven to show its outstanding effectiveness and safety without any side effects until now.”
The treatment is allegedly free from side-effects, with the Journal of Dermatology and other industry publications offering the ingredient positive coverage.
AesMed is responsible for the design and development of medical devices and beauty products in South Korea and, since 2007, it has provided products to cosmetic surgery clinics and dermatology departments. The latest advanced technology has been used in the development of SGF-57, and it's hoped that this new ingredient could be used to treat those affected by Alopecia.
Although the precise cause is unknown, Alopecia Areata is classified as an auto-immune disorder. It is thought to be triggered by stressful or emotional events, leading to patchy hair loss which could even develop into total hair loss on the head or body (Alopecia Totalis and Alopecia Universalis respectively).
There are a few types of treatment for Alopecia Areata available at the moment, including minoxidil, an effective hair loss treatment that has been medically-proven to treat both male and female pattern hair loss, and which has also been seen to produce promising regrowth in many Alopecia Areata clients here at Belgravia, including Mr. H, pictured right. Unfortunately, treatment for Alopecia Totalis and Universalis is much more difficult, with a lower success rate.
If you are worried about Alopecia Areata or any other hair loss condition, you should contact a specialist as soon as possible, so that a bespoke hair loss treatment programme can be tailored to suit your individual needs.
The Belgravia Centre is a world-renowned group of a hair loss clinic in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation from anywhere in the world for home-use treatment.
View our Hair Loss Success Stories, which includes the world's largest gallery of hair growth photos and demonstrates the level of success that so many of Belgravia's patients achieve.